Funding for medical technologies in October 2014 totaled $332 million, led by the $59 million funding of Ivantis, Inc., and the $55 million funding of PureTech.
Below are the top fundings for the month:
|Ivantis, Inc., has raised $58.87 million of a $71.37 million round of fundng according to a regulatory filing||Stent-based treatment to lower intraocular pressure in glaucoma|
|PureTech has raised $55 million in a round of funding according to the company||Medical device and other technologies spanning treatments in immunology, metabolism, neuroscience, drug delivery and consumer digital health|
|VytronUS, Inc., has raised $31.6 million in a Series B round of funding according to the company||Integrated imaging and ultrasound ablation for treatment of cardiac arrhythmias|
|Respicardia, Inc., has raised $25.09 million in a round of funding according to a regulatory filing||Electrical pulse-based implant treatment for sleep apnea|
|Magnus Life Science (Magnus Life Ltd) has raised £15.5 million ($24.96 million) in a round of funding according to regulatory filing||Device and non-device technologies based on dynamics of bloodflow|
|Medrobotics Corp. has raised $20 million in a preferred stock offering according to the company||Computer-assisted access and visualization system for minimally invasive robotic surgery|